TORONTO, Ont., July 11, 2011More patients are tested and treated for osteoporosis when fracture clinics have someone dedicated to screening for the bone disease, a new study has found.
Those patients also do better when the clinic actually provides bone mineral density (BMD) testing or prescription drug treatment as part of its program rather than just referring fracture patients elsewhere.
Researchers at St. Michael's Hospital led by Joanna Sale, a clinical epidemiologist, reviewed osteoporosis screening and management programs involving patients treated for fragility fractures by orthopedic staff in 11 countries.
The study, published in the journal Osteoporosis International, was unusual in that it examined both randomized trials and clinical programs available to all patients.
"We found that patient outcomes were better with programs that had dedicated personnel to test for and treat the disease," said Sale, an associate scientist in the hospital's Mobility Program Clinical Research Unit.
"A fracture clinic is a very busy place. Patients are in pain. You have orthopedic surgeons, residents, physiotherapists, orthopedic technicians. It makes sense to have someone who can identify patients who might have osteoporosis, educate them, refer them for a bone mineral density test, schedule them for the test and write a prescription.
"Outcomes are also better when the test or treatment takes place within the program, rather than sending the patient elsewhere and potentially losing contact with them."
Sale said the review had some challenges with comparing data across studies. Some programs reported statistics based on all patients, others based only on patients who went for bone density tests and still others based on bone density scores. An important consideration for future research is the need to standardize reporting, she said.
Osteoporosis is a disease characterized by low bone
|Contact: Leslie Shepherd|
St. Michael's Hospital